Clot-busting drug after stroke in people on newer blood thinners
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a clot-busting medication given through a vein (intravenous thrombolysis) can safely treat acute ischemic stroke within 24 hours in people who have taken a newer oral blood thinner (NOAC) within the last 4 to 48 hours.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You had a stroke that started within the last 24 hours (or you woke up with stroke symptoms that likely started within 24 hours).
- You took a new oral blood thinner (like apixaban, rivaroxaban, or edoxaban) within 4 to 48 hours before your stroke symptoms began.
- You are not planning to have a clot-removal procedure (endovascular treatment).
- You do not have any conditions that make it unsafe to receive clot-busting medication, such as active bleeding, recent surgery, high blood pressure, or low blood platelets.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a clot-dissolving medicine can help people who had a mild ischemic stroke and also had a prior stroke in the last 3 months. It aims to see if the treatment is safe and effective for this specific group.
This study tests whether a clot-busting medicine (thrombolysis) can safely treat acute ischemic stroke in people who also have active cancer. It aims to see if the benefits of the treatment outweigh the bleeding risks for this group.
This trial tests if a medication called tirofiban can help people who had a stroke 4.5 to 24 hours ago and received clot-dissolving treatment (IVT). If you have had a stroke and your symptoms did not improve or got worse after IVT, this study might offer a way to prevent further disability.
This trial tests whether giving an antiplatelet medicine (like aspirin) early—within 3 hours of a clot-busting drug—can help prevent another stroke without causing bleeding. It is for people who still have moderate to severe stroke symptoms after the clot-buster and do not have a large artery blockage.
This trial tests whether a clot-busting drug called tenecteplase works safely in people having a stroke who are already taking certain blood-thinning medications (like apixaban or rivaroxaban). The goal is to see if it can restore blood flow to the brain better than current treatments.
This trial tests whether injecting a blood thinner called tirofiban directly into brain blood vessels during a stroke procedure helps prevent clots from forming again. If you've had a stroke caused by a large clot in your brain that was successfully removed, this study may help protect your recovery.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.